Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Author
gptkb:Scientist |
| gptkbp:affiliation |
gptkb:California_Institute_of_Technology
gptkb:SRI_International |
| gptkbp:awards |
Psychedelic Science Award
Lifetime Achievement Award from the Multidisciplinary Association for Psychedelic Studies |
| gptkbp:birth_date |
1925-06-17
|
| gptkbp:birth_place |
gptkb:Berkeley,_California,_USA
|
| gptkbp:contribution |
development of new psychoactive substances
popularizing MDMA research on 2 C-B research on DMT research on LSD research on mescaline |
| gptkbp:death_date |
2014-06-02
|
| gptkbp:education |
gptkb:University_of_California,_Berkeley
|
| gptkbp:field |
pharmacology
psychedelics |
| https://www.w3.org/2000/01/rdf-schema#label |
Alexander Shulgin
|
| gptkbp:influence |
gptkb:traditional_medicine
drug design psychedelic culture research on consciousness advocacy for responsible use of psychedelics modern psychopharmacology community of psychonauts cultural attitudes towards psychedelics harm reduction in drug use integration of psychedelics into psychotherapy self-experimentation in drug research spiritual use of psychedelics scientific exploration of altered states of consciousness |
| gptkbp:influenced |
psychedelic community
therapeutic use of psychedelics |
| gptkbp:influenced_by |
gptkb:Albert_Hofmann
|
| gptkbp:involvement |
scientific publications
drug policy reform psychedelic therapy psychedelic research community public speaking on psychedelics |
| gptkbp:known_for |
psychedelic research
synthesis of psychoactive compounds |
| gptkbp:legacy |
Shulgin method
Shulgin scale |
| gptkbp:nationality |
gptkb:American
|
| gptkbp:notable_work |
gptkb:PIHKAL
gptkb:TIHKAL |
| gptkbp:occupation |
gptkb:Scientist
gptkb:Writer |
| gptkbp:research_focus |
drug development
psychoactive substances |
| gptkbp:spouse |
gptkb:Ann_Shulgin
|
| gptkbp:bfsParent |
gptkb:Igor_Shulgin
|
| gptkbp:bfsLayer |
4
|